Piper Sandler Maintains Orchestra BioMed(OBIO.US) With Buy Rating, Maintains Target Price $15

Moomoo News13:31 ET · Ratings

Major Shareholder Boosts Investment in Orchestra BioMed Holdings!

TipRanksApr 29 22:11 ET

Orchestra BioMed Receives US FDA Approval for Heart Device Trial

MT NewswiresApr 29 12:45 ET

Orchestra BioMed Holdings: FDA Approves IDE Amendment To Initiate Updated Design Of Virtue SAB In Treatment Of Coronary ISR Trial

BenzingaApr 29 09:02 ET

Express News | Orchestra Biomed Holdings Inc: Targeting Initiation of Virtue Trial During Second Half of 2025

ReutersApr 29 09:01 ET

Express News | Orchestra Biomed Receives FDA Approval of Ide to Initiate U.S. Coronary Pivotal Trial Randomizing First-in-Class Sirolimus-Angioinfusion Balloon, Virtue SAB, Head-to-Head With Paclitaxel-Coated Balloon

ReutersApr 29 09:00 ET

Orchestra BioMed Receives FDA Approval of IDE to Initiate U.S. Coronary Pivotal Trial Randomizing First-in-Class Sirolimus-AngioInfusion Balloon, Virtue SAB, Head-to-Head With Paclitaxel-Coated Balloon

GlobeNewswireApr 29 09:00 ET

Orchestra BioMed to Participate in Upcoming Institutional Investor Conferences

GlobeNewswireApr 28 16:30 ET

H.C. Wainwright Maintains Orchestra BioMed(OBIO.US) With Buy Rating, Maintains Target Price $12

Moomoo NewsApr 23 13:32 ET · Ratings

Orchestra BioMed Announces AVIM Therapy-Focused Satellite Symposium at HRS 2025 Annual Meeting

GlobeNewswireApr 23 09:00 ET

Vivasure Medical Receives CE Mark Approval in Europe for PerQseal Elite Vascular Closure System

BusinesswireApr 22 09:36 ET

Ocean Biomedical OCEA Cryptocurrency Strategy; Orchestra BioMed OBIO Breakthrough Device Designation

BioPharmCatalystApr 22 08:53 ET

Orchestra BioMed Shares Rally After FDA Breakthrough Approval for Blood-Pressure Device

Dow JonesApr 22 08:02 ET

Express News | Orchestra Biomed Receives FDA Breakthrough Device Designation for Avim Therapy

ReutersApr 22 07:00 ET

Orchestra BioMed Receives FDA Breakthrough Device Designation for AVIM Therapy

GlobeNewswireApr 22 07:00 ET

Orchestra BioMed's Strategic Advances in Medical Innovations

TipRanksApr 7 23:51 ET

Top 10 Russell 2000 Weekly Gainers and Losers as Wall Street Crashes

Seeking AlphaApr 5 17:55 ET

H.C. Wainwright Maintains Orchestra BioMed(OBIO.US) With Buy Rating, Cuts Target Price to $12

Moomoo NewsApr 4 13:31 ET · Ratings

Is Orchestra BioMed Holdings (NASDAQ:OBIO) Using Debt Sensibly?

Simply Wall StApr 4 07:21 ET

Express News | Orchestra Biomed Holdings, Inc. : H.c. Wainwright Cuts Target Price to $12 From $14

ReutersApr 4 06:09 ET